Influence of the site of arterial occlusion on multiple baseline hemodynamic MRI parameters and post-thrombolytic recanalization in acute stroke

被引:31
作者
Derex, L
Hermier, M
Adeleine, P
Pialat, JB
Wiart, M
Berthezène, Y
Froment, JC
Trouillas, P
Nighoghossian, N
机构
[1] Hop Neurol, Serv Urgences Neurovasc, F-69003 Lyon, France
[2] Hospices Civils Lyon, Serv Biostat, Lyon, France
[3] Hop Neurol, Serv Neuroradiol, Lyon, France
[4] CREATIS, CNRS, UMR 5515, INSERM,U630, Lyon, France
关键词
acute stroke; MRI; perfusion-weighted imaging; thrombolysis;
D O I
10.1007/s00234-004-1279-y
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In this prospective MRI study, we evaluated the impact of the site of occlusion on multiple baseline perfusion parameters and subsequent recanalization in 49 stroke patients who were given intravenous tissue plasminogen activator (tPA). Pretreatment magnetic resonance angiography (MRA) revealed an arterial occlusion in 47 patients: (1) internal carotid artery (ICA)+M1 middle cerebral artery (MCA) occlusion (n=12); (2) M1 MCA occlusion (n=19); (3) M2 MCA, distal branches of the MCA and anterior cerebral artery (ACA) occlusion (n=16). Patients with ICA occlusion had significantly larger DWI, PWI and mismatch lesion volume on pretreatment MRI compared to patients with other sites of occlusion. The differences in cerebral blood flow (CBF) and peak height were significantly higher in patients with ICA occlusion compared to patients with other sites of occlusion (P=0.03 and P=0.04, respectively). Day 1 MRA showed recanalization in 28 patients (60%). The rate of recanalization was significantly different depending on the site of occlusion: 33% in ICA+M1 MCA occlusion, 63% in M1 MCA occlusion and 81% in either M2 MCA, distal branches of the MCA or ACA occlusion (P=0.002). Our data suggest that CBF and peak height are the most relevant MRI parameters to assess the severity of hemodynamic impairment in regard to the site of occlusion.
引用
收藏
页码:883 / 887
页数:5
相关论文
共 18 条
[1]   Absent middle cerebral artery flow predicts the presence and evolution of the ischemic penumbra [J].
Barber, PA ;
Davis, SM ;
Darby, DG ;
Desmond, PM ;
Gerraty, RP ;
Yang, Q ;
Jolley, D ;
Donnan, GA ;
Tress, BM .
NEUROLOGY, 1999, 52 (06) :1125-1132
[2]   MEASUREMENTS OF ACUTE CEREBRAL INFARCTION - A CLINICAL EXAMINATION SCALE [J].
BROTT, T ;
ADAMS, HP ;
OLINGER, CP ;
MARLER, JR ;
BARSAN, WG ;
BILLER, J ;
SPILKER, J ;
HOLLERAN, R ;
EBERLE, R ;
HERTZBERG, V ;
RORICK, M ;
MOOMAW, CJ ;
WALKER, M .
STROKE, 1989, 20 (07) :864-870
[3]   RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE THROMBOTIC AND EMBOLIC STROKE [J].
DELZOPPO, GJ ;
POECK, K ;
PESSIN, MS ;
WOLPERT, SM ;
FURLAN, AJ ;
FERBERT, A ;
ALBERTS, MJ ;
ZIVIN, JA ;
WECHSLER, L ;
BUSSE, O ;
GREENLEE, R ;
BRASS, L ;
MOHR, JP ;
FELDMANN, E ;
HACKE, W ;
KASE, CS ;
BILLER, J ;
GRESS, D ;
OTIS, SM .
ANNALS OF NEUROLOGY, 1992, 32 (01) :78-86
[4]   Which MR-derived perfusion parameters are the best predictors of infarct growth in hyperacute stroke? Comparative study between relative and quantitative measurements [J].
Grandin, CB ;
Duprez, TP ;
Oppenheim, C ;
Peeters, A ;
Robert, AR ;
Cosnard, G .
RADIOLOGY, 2002, 223 (02) :361-370
[5]   Clinical and vascular outcome in internal carotid artery versus middle cerebral artery occlusions after intravenous tissue plasminogen activator [J].
Linfante, I ;
Llinas, RH ;
Selim, M ;
Chaves, C ;
Kumar, S ;
Parker, RA ;
Caplan, LR ;
Schlaug, G .
STROKE, 2002, 33 (08) :2066-2071
[6]   Evaluation of early reperfusion and IV tPA therapy using diffusion- and perfusion-weighted MRI [J].
Marks, MP ;
Tong, DC ;
Beaulieu, C ;
Albers, GW ;
de Crespigny, A ;
Moseley, ME .
NEUROLOGY, 1999, 52 (09) :1792-1798
[7]   TISSUE-PLASMINOGEN ACTIVATOR FOR ACUTE ISCHEMIC STROKE [J].
MARLER, JR ;
BROTT, T ;
BRODERICK, J ;
KOTHARI, R ;
ODONOGHUE, M ;
BARSAN, W ;
TOMSICK, T ;
SPILKER, J ;
MILLER, R ;
SAUERBECK, L ;
JARRELL, J ;
KELLY, J ;
PERKINS, T ;
MCDONALD, T ;
RORICK, M ;
HICKEY, C ;
ARMITAGE, J ;
PERRY, C ;
THALINGER, K ;
RHUDE, R ;
SCHILL, J ;
BECKER, PS ;
HEATH, RS ;
ADAMS, D ;
REED, R ;
KLEI, M ;
HUGHES, S ;
ANTHONY, J ;
BAUDENDISTEL, D ;
ZADICOFF, C ;
RYMER, M ;
BETTINGER, I ;
LAUBINGER, P ;
SCHMERLER, M ;
MEIROSE, G ;
LYDEN, P ;
RAPP, K ;
BABCOCK, T ;
DAUM, P ;
PERSONA, D ;
BRODY, M ;
JACKSON, C ;
LEWIS, S ;
LISS, J ;
MAHDAVI, Z ;
ROTHROCK, J ;
TOM, T ;
ZWEIFLER, R ;
DUNFORD, J ;
ZIVIN, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (24) :1581-1587
[8]   INTRAVENOUS RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE CAROTID-ARTERY TERRITORY STROKE [J].
MORI, E ;
YONEDA, Y ;
TABUCHI, M ;
YOSHIDA, T ;
OHKAWA, S ;
OHSUMI, Y ;
KITANO, K ;
TSUTSUMI, A ;
YAMADORI, A .
NEUROLOGY, 1992, 42 (05) :976-982
[9]   Diffusion- and perfusion-weighted MRI -: Influence of severe carotid artery stenosis on the DWI/PWI mismatch in acute stroke [J].
Neumann-Haefelin, T ;
Wittsack, HJ ;
Fink, GR ;
Wenserski, F ;
Li, TQ ;
Seitz, RJ ;
Siebler, M ;
Mödder, U ;
Freund, HJ .
STROKE, 2000, 31 (06) :1311-1317
[10]   Baseline magnetic resonance imaging parameters and stroke outcome in patients treated by intravenous tissue plasminogen activator [J].
Nighoghossian, N ;
Hermier, M ;
Adeleine, P ;
Derex, L ;
Dugor, JF ;
Philippeau, F ;
Ylmaz, H ;
Honnorat, J ;
Dardel, P ;
Berthezéne, Y ;
Froment, JC ;
Trouillas, P .
STROKE, 2003, 34 (02) :458-463